Daniel R. Chard - 21 Feb 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
21 Feb 2023
Net transactions value
-$209,288
Form type
4
Filing time
22 Feb 2023, 20:57:50 UTC
Previous filing
11 May 2022
Next filing
01 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability $209,288 -1,815 -11% $115.31 14,118 21 Feb 2023 Direct F1, F2
holding MED Common Stock 108,598 21 Feb 2023 The Dan and Allyson Family Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld to satisfy the tax withholding obligations upon vesting of an equity award.
F2 This equity award vested on February 19, 2023, which fell on a weekend. The price used for the withholding was the closing sales price for the most recent trading day prior to the vesting date.
F3 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.